This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Friday's Small-Cap Winners & Losers





Odyssey Healthcare's (ODSY) rating was upped to buy from hold by a Deutsche Securities analyst, sending the Dallas-based company's shares up $1.17, or 9%, to $14.21.

Amcol International (ACO) reported soaring fourth-quarter profits. Earnings for the quarter totaled $12 million, or 39 cents a share, compared with $8.4 million, or 27 cents a share, a year ago.

Excluding a tax-cut benefit of 3 cents a share, income beat estimates by 2 cents a share. Fourth-quarter revenue climbed 16% to $155.9 million from a year ago, which eclipses the $155.1 million projection. Shares were gaining $2.05, or 7.9%, to $28.70.

Enterra Energy Trust (ENT) tumbled after the Canada-based driller halved its monthly dividend to 6 cents a share. Shares were falling $1.26, or 15.5%, to $6.88.

Pharmos (PARS) sank after the biotech announced that its proposed synthetic cannabinoid compound didn't relieve a particular model of induced pain, as compared with a placebo, in midphase testing.

The Iselin, N.J.-based company said that the compound, which is chemically related to marijuana, was nonetheless well tolerated. Shares were losing 19 cents, or 10.5%, to $1.62.

Irvine Sensors (IRSN) slid after the Costa Mesa, Calif., chipmaker said it will be late with its 2006 financials, which were due Jan. 18. The company says it will file the results "as soon as possible." Shares were down 9 cents, or 5.5%, to $1.55.

2 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,614.81 +215.14 1.31%
S&P 500 1,941.28 +37.27 1.96%
NASDAQ 4,419.4780 +103.4040 2.40%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs